Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 35 Neoplasms 23 Motor Activity 11 Stomach Neoplasms 7 Pain, Postoperative 7 Lung Neoplasms 7 Fatigue 7 Colorectal Neoplasms 7 Pain 5 Anxiety Disorders 5 Polycystic Ovary Syndrome 4 Depression 4 Carcinoma, Hepatocellular 4 Uterine Cervical Neoplasms 3 Thyroid Neoplasms 3 Stomatitis 3 Sleep Initiation and Maintenance Disorders 3 Rectal Neoplasms 3 Prostatic Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Malnutrition 3 Liver Neoplasms 3 Leukemia, Myeloid, Acute 3 Colonic Neoplasms 3 Agnosia 3 Vomiting 2 Urinary Incontinence 2 Squamous Cell Carcinoma of Head and Neck 2 Parasomnias 2 Ovarian Neoplasms 2

Interventions

Carmustine 2 poly ICLC 1 dapagliflozin 1 Topotecan 1 Tomography, X-Ray Computed 1 Magnetoencephalography 1 Magnetic Resonance Imaging 1 High-Intensity Interval Training 1 Diet, Ketogenic 1 Cyclophosphamide 1 Control Groups 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Pediatric Brain Tumor × Control Groups × Clear all

NCT05740839 2026-02-24

HYPE

Dana-Farber Cancer Institute

Phase NA Recruiting

Pediatric Brain Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡